Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LOFEXIDINE HYDROCHLORIDE
- Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids
- Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
- Sublingual Dexmedetomidine for Treating Opioid Withdrawal
- Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse
- Evaluating Buspirone to Treat Opioid Withdrawal
- Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder
- Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
- Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
- Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans
- An Innovative Intervention for OUD Treatment
- Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal
- A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution
- Lofexidine for Adults Undergoing Lumbar Spine Surgery
- Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal
- Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment
- Impact of Lofexidine on Stress, Craving and Opioid Use
- Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
- Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers
- Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects
- Open-Label, Safety Study of Lofexidine
- Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects
- Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired Subjects
- Metoclopramide as Treatment of Clozapine-induced Hypersalivation
- Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal
- Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
- Lofexidine for Inpatient Opiate Detox in Singapore
- Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
- Lofexidine Mass Balance in Volunteers
- Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
- Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence
- Lofexidine Food Effect Study in Healthy Volunteers
- Lofexidine ADME & Mass Balance in Volunteers
- Interactions Between Intravenous (IV) Cocaine and Lofexidine
- Combined Pharmacotherapy for Cannabis Dependency
- Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse
- Lofexidine for Inpatient Opiate Detox
- Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1
- Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1
- Lofexidine for Opiate Withdrawal - 1
- Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
- Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
- Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
Clinical trials list
click for details